Related Experiment Video

Updated: Apr 14, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?

A Coosemans1, T Baert1, I Vergote2

  • 1Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. ; UZ Leuven, Gynaecology and Obstetrics, Herestraat 49, 3000 Leuven, Belgium.

Facts, Views & Vision in Obgyn
|April 22, 2015
PubMed

Insights

Ovarian cancer remains a deadly gynecologic malignancy, necessitating novel treatments. This review explores the potential of dendritic cell immunotherapy to harness the immune system against this immunogenic tumor.

Area of Science:

  • Gynecologic Oncology
  • Immunology
  • Cancer Research

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer mortality, with a high fatality rate.
  • Despite being an immunogenic tumor, ovarian cancer has historically seen limited development in immunotherapy.
  • Effective treatment strategies for ovarian cancer are urgently needed.

Purpose of the Study:

  • To highlight the critical role of the immune system in ovarian cancer development and progression.
  • To discuss the potential of dendritic cell-based immunotherapy for ovarian cancer.
  • To identify challenges and opportunities in developing dendritic cell immunotherapy for ovarian cancer.

Main Methods:

  • Literature review focusing on the immunology of ovarian cancer.
  • Analysis of existing research on dendritic cell biology and function.
  • Exploration of preclinical and clinical data regarding dendritic cell immunotherapy in gynecologic malignancies.

Main Results:

  • The immune system significantly influences ovarian cancer progression.
  • Dendritic cells are potent antigen-presenting cells crucial for initiating anti-tumor immune responses.
  • Dendritic cell-based immunotherapy shows promise but faces challenges in optimization and delivery.

Conclusions:

  • Harnessing the immune system, particularly via dendritic cell immunotherapy, offers a promising avenue for treating ovarian cancer.
  • Further research is required to overcome current limitations and translate the potential of dendritic cell immunotherapy into effective clinical practice.
  • Understanding the interplay between ovarian cancer and the immune microenvironment is key to developing successful immunotherapeutic strategies.
Keywords:
DCOvarian cancercancerdendritic cellimmunotherapytargeted therapy

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K